Investment25 Jul 2025, 07:34 pm
Dr Reddy's Laboratories Infuses Rs. 565 Crores in Russian Subsidiary for 45.19% Stake
AI Summary
Dr Reddy's Laboratories Ltd has invested Rs. 565,40,77,993/- in its step-down wholly-owned subsidiary, Dr. Reddy’s Laboratories LLC, Russia (DRL Russia), for a total equity stake of 45.19%. The investment, which is a related party transaction, was made on July 25, 2025, and will be used for working capital requirements. DRL Russia, a Pharmaceutical company registered in Russian Federation, was incorporated on 5th of April 2003 and has a turnover of Rs. 2,347 Cr in FY2025.
Key Highlights
- Dr Reddy's Laboratories has invested Rs. 565 Crores in its Russian subsidiary, DRL Russia.
- The investment gives Dr Reddy's a 45.19% stake in DRL Russia.
- The investment is a related party transaction.
- The funds will be used for working capital requirements of DRL Russia.
- DRL Russia is a Pharmaceutical company registered in Russian Federation with a turnover of Rs. 2,347 Cr in FY2025.